Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Support

This activity is supported by an educational grant from Incyte Corporation.

Onco-Nurse Academy (Virtual Grand Rounds Edition): Navigating Cholangiocarcinoma Management With Targeted and Immunotherapies

Release Date: July 28, 2021
Expiration Date: July 28, 2022

Activity Overview

This online, on-demand virtual symposium features a renowned expert in the management of cholangiocarcinoma who presents and applies recent clinical trial evidence to solve challenging problems in the management of this aggressive malignancy. This activity seeks to provide practical solutions to common issues faced by oncology nursing professionals and other members of the multidisciplinary team throughout the management of cholangiocarcinoma.

This educational activity is an archive of the live virtual symposium held on July 12, 2021.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward nurses and other health care professionals with an interest in the treatment of gastrointestinal cancers.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:
  • Evaluate the rationale for emerging targeted and immunotherapeutic strategies and their application in cholangiocarcinoma
  • Assess the efficacy and safety profiles of emerging agents and combinations evaluated in patients with cholangiocarcinoma
  • Implement multidisciplinary strategies to identify and mitigate toxicities associated with current and emerging therapies for cholangiocarcinoma
  • Apply knowledge of treatment-related toxicities and testing strategies to inform effective counseling and care coordination for patients with cholangiocarcinoma

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.


Gabriel Schwartz, MSN, FNP-BC, AOCNP
Gabriel Schwartz, MSN, FNP-BC, AOCNP
Nurse Practitioner
Department of GI Medical Oncology
Assistant Clinical Professor
Department of Family Healthcare Nursing
University of California, San Francisco Medical Center
San Francisco, California

Disclosures: Consultant: Exelixis; Speaker’s Bureau: Eisai.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By